Published by mark itwired
Posted on October 4, 2021
According to a recent study by Future Market Insights (FMI), sales of infection prevention products are expected to top US$ 37.4 Bn in 2021, at a CAGR of over 4.2% during the forecast period (2021-2031).
Rising cases of infectious diseases caused due to the pathogenic organisms such as bacteria, fungi, viruses and other parasitic organism are improving the adoption of infection preventing products.
As reported by the Centre for Disease Control and Prevention (CDC) in 2018, infectious disease is the third most leading cause of death in the U.S. followed by other infectious diseases such as tuberculosis (9,025 cases), salmonella (60,99 cases), Lyme disease (33,666 cases), meningococcal disease (327 cases) and parasitic diseases (15.5 Mn cases).
Several other factors such as rising incidence of infections acquired while in hospital (often called as Hospital Acquired Infections or HAI), large number of surgical procedures, and increasing cases of chronic diseases among geriatric population have led to higher emphasis on maintaining proper hygiene and cleanliness.
Sudden outbreak of pandemic increased the number of patients in hospital during the FQ-20, elevating the risk of viral transmission amongst them. This in turn has created the demand for infection preventing and controlling options such as the use of hand sanitizers, disinfectants and other such products.
Increase in sales of these infection prevention products is expected to boost the infection prevention market growth in near future. The market registered spike in demand for infection preventive products, especially in emerging economies such as India.
As per Future Market Insights, the India infection prevention market registered highest growth across South Asia, reaching US$ 17.29 Bn in 2021.
Additionally, companies manufacturing infection prevention products have been focusing on developing eco- friendly and sustainable bio-based products with superior efficacy. Drive towards sustainability is expected to strengthen infection prevention market, creating worthwhile opportunities for growth.
Increasing ageing population worldwide has resulted in higher focus on proper hygiene and self-care solutions due to the rise in chronic diseases and onset of COVID-19. Furthermore, increase in consumer spending, improved healthcare infrastructure, rising government and industry investments in research and development activities will create demand for infection prevention product.
Based on the aforementioned factors, Future Market Insights (FMI) estimates that the market is expected to create absolute $ opportunity, exceeding more than US$ 56.39 Bn by 2031-end.
Request The Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13950
“Backed by the unprecedented outbreak of COVID-19, demand for infection preventing products is increasing. Key players are introducing products made from sustainable and eco-friendly materials to gain competitive edge,” says the FMI Analyst.
Some of the leading manufacturers of infection prevention products are focusing on new product development, clinical trials, speedy regulatory approvals, exclusive marketing and distribution licensing agreement strategies, thereby enhancing their market presence.
Clean & Protect Certified Badge Program was launched by 3M company. A new comprehensive system designed for effective cleaning and disinfecting solution that cleans, monitors and protects the facilities.The key market players covered by FMI include Cantel Medical, Getinge AB, STERIS, ASP (Advanced sterilization Products), Sotera Health, 3M, Ecolab, Halyard Worldwide, Inc. (Halyard health), Matachana Group, Belimed, Inc., Pal International, Reckitt Benckiser Group PLC., Metrex Research, LLC., Terumo Corporation, Ahlstrom Munksjo and Ansell Ltd.
Speak To Analyst about queries @ https://www.futuremarketinsights.com/ask-question/rep-gb-13950
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3.1. Key Trends Impacting the Market
3.2. Drug Development Trends
4.1. Macro-Economic Factors
4.1.1. Global Healthcare Industry Outlook
4.1.2. COVID-19 Outbreak: Short-term Benefits for Disinfectant Chemical Companies
4.1.3. Steady Growth in Specialty Chemicals Industry to Boost Market Growth
4.2. Forecast Factors – Relevance & Impact
4.2.1. Incidence of Infection
4.2.2. Regulatory Imposition on Infection Prevention Products
4.2.3. Infection Prevention Products Pipeline Assessment
4.2.4. Incremental R&D by Product-Based Companies
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
5.1. Product Adoption / Usage Analysis
5.2. Product USPs / Features
5.3. Strategic Promotional Strategies, By Key Manufacturers
5.4. Infection Prevention Products adoption, By Region
5.5. Key Regulations, By Region
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. COVID19 and Impact Analysis
6.4. 2020 Market Scenario
6.5. Recovery Scenario – Short term, Midterm and Long Term Impact
The post The Infection prevention Market is projected to rise at a CAGR of 4.2% through 2031 appeared first on Market Research Blog.
According to a recent study by Future Market Insights (FMI), sales of infection prevention products are expected to top US$ 37.4 Bn in 2021, at a CAGR of over 4.2% during the forecast period (2021-2031).
Rising cases of infectious diseases caused due to the pathogenic organisms such as bacteria, fungi, viruses and other parasitic organism are improving the adoption of infection preventing products.
As reported by the Centre for Disease Control and Prevention (CDC) in 2018, infectious disease is the third most leading cause of death in the U.S. followed by other infectious diseases such as tuberculosis (9,025 cases), salmonella (60,99 cases), Lyme disease (33,666 cases), meningococcal disease (327 cases) and parasitic diseases (15.5 Mn cases).
Several other factors such as rising incidence of infections acquired while in hospital (often called as Hospital Acquired Infections or HAI), large number of surgical procedures, and increasing cases of chronic diseases among geriatric population have led to higher emphasis on maintaining proper hygiene and cleanliness.
Sudden outbreak of pandemic increased the number of patients in hospital during the FQ-20, elevating the risk of viral transmission amongst them. This in turn has created the demand for infection preventing and controlling options such as the use of hand sanitizers, disinfectants and other such products.
Increase in sales of these infection prevention products is expected to boost the infection prevention market growth in near future. The market registered spike in demand for infection preventive products, especially in emerging economies such as India.
As per Future Market Insights, the India infection prevention market registered highest growth across South Asia, reaching US$ 17.29 Bn in 2021.
Additionally, companies manufacturing infection prevention products have been focusing on developing eco- friendly and sustainable bio-based products with superior efficacy. Drive towards sustainability is expected to strengthen infection prevention market, creating worthwhile opportunities for growth.
Increasing ageing population worldwide has resulted in higher focus on proper hygiene and self-care solutions due to the rise in chronic diseases and onset of COVID-19. Furthermore, increase in consumer spending, improved healthcare infrastructure, rising government and industry investments in research and development activities will create demand for infection prevention product.
Based on the aforementioned factors, Future Market Insights (FMI) estimates that the market is expected to create absolute $ opportunity, exceeding more than US$ 56.39 Bn by 2031-end.
Request The Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13950
“Backed by the unprecedented outbreak of COVID-19, demand for infection preventing products is increasing. Key players are introducing products made from sustainable and eco-friendly materials to gain competitive edge,” says the FMI Analyst.
Some of the leading manufacturers of infection prevention products are focusing on new product development, clinical trials, speedy regulatory approvals, exclusive marketing and distribution licensing agreement strategies, thereby enhancing their market presence.
Clean & Protect Certified Badge Program was launched by 3M company. A new comprehensive system designed for effective cleaning and disinfecting solution that cleans, monitors and protects the facilities.The key market players covered by FMI include Cantel Medical, Getinge AB, STERIS, ASP (Advanced sterilization Products), Sotera Health, 3M, Ecolab, Halyard Worldwide, Inc. (Halyard health), Matachana Group, Belimed, Inc., Pal International, Reckitt Benckiser Group PLC., Metrex Research, LLC., Terumo Corporation, Ahlstrom Munksjo and Ansell Ltd.
Speak To Analyst about queries @ https://www.futuremarketinsights.com/ask-question/rep-gb-13950
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3.1. Key Trends Impacting the Market
3.2. Drug Development Trends
4.1. Macro-Economic Factors
4.1.1. Global Healthcare Industry Outlook
4.1.2. COVID-19 Outbreak: Short-term Benefits for Disinfectant Chemical Companies
4.1.3. Steady Growth in Specialty Chemicals Industry to Boost Market Growth
4.2. Forecast Factors – Relevance & Impact
4.2.1. Incidence of Infection
4.2.2. Regulatory Imposition on Infection Prevention Products
4.2.3. Infection Prevention Products Pipeline Assessment
4.2.4. Incremental R&D by Product-Based Companies
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
5.1. Product Adoption / Usage Analysis
5.2. Product USPs / Features
5.3. Strategic Promotional Strategies, By Key Manufacturers
5.4. Infection Prevention Products adoption, By Region
5.5. Key Regulations, By Region
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. COVID19 and Impact Analysis
6.4. 2020 Market Scenario
6.5. Recovery Scenario – Short term, Midterm and Long Term Impact
The post The Infection prevention Market is projected to rise at a CAGR of 4.2% through 2031 appeared first on Market Research Blog.
Explore more articles in the Research Reports category
